Cellular senescence and failure of myelin repair in multiple sclerosis
Open accessThe DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Abstract
Remyelination is a physiological response to demyelinating events aiming to restore saltatory conduction and preserve axonal integrity. Resident oligodendrocyte precursor cells (OPC) of the CNS tissue under appropriate conditions are mobilized to proliferate, migrate, and differentiate, in order to produce new myelin sheaths in the demyelinated lesion. In multiple sclerosis (MS), the most common immune-mediated demyelinating disease, remyelination efficiency declines with increasing age and disease duration. As myelin regeneration attempts in clinical trials so far are scarce, and have been met with limited success, the need to explore new remyelinating strategies is more compelling. Recently, ageing and cellular senescence have been implicated in the pathophysiology of a number of neurodegenerative diseases, including multiple sclerosis. Evidence on OPC senescence brings forward the possibility of exploiting cellular senescence as a possible target for promoting the endogenous remyelinating capacity of the CNS. Here we discuss the data indicating how cellular senescence affects remyelination, and the putative benefits to be drawn through the use of senolytic or senomorphic therapies targeting senescent cell populations in MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 2×
“Models of accelerated cellular senescence show premature ageing and indicate that cellular senescence may contribute to neurodegeneration associated with ageing and age-related conditions (Baker et al., 2011; Kevin Howcroft et al., 2013; Kritsilis et al., 2018).”
BackgroundCellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225
Self-citationHallmarks of Cellular Senescence
Hernandez-Segura, A., Nehme, J., & Demaria, M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.02.001 · Cited by 2,605
Four faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070 · cited 2×
“Most of these triggers lead to DNA damage and typically activate the complex signal transduction system of DNA damage response (DDR), which may elicit CS (Nakamura et al., 2008; Rodier and Campisi, 2011; Turenne et al., 2001).”
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
Self-citationOcrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
Montalban, X., Hauser, S. L., Kappos, L., Arnold, D. L., Bar-Or, A., Comi, G., de Seze, J., Giovannoni, G., Hartung, H.-P., Hemmer, B., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606468 · Cited by 1,905
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., van Wijngaarden, P., Wagers, A. J., Williams, A., Franklin, R. J. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3469 · Cited by 1,777
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity
Fünfschilling, U., Supplie, L. M., Mahad, D., Boretius, S., Saab, A. S., Edgar, J., Brinkmann, B. G., Kassmann, C. M., Tzvetanova, I. D., Möbius, W., et al. (2012) · Nature · doi:10.1038/nature11007 · Cited by 1,523
Autophagy maintains stemness by preventing senescence
García-Prat, L., Martínez-Vicente, M., Perdiguero, E., Ortet, L., Rodríguez-Ubreva, J., Rebollo, E., Ruiz-Bonilla, V., Gutarra, S., Ballestar, E., Serrano, A. L., et al. (2016) · Nature · doi:10.1038/nature16187 · Cited by 1,355 · cited 1×
“Ageing has been shown to affect the capacity for myelin repair in several animal models of demyelination (Cantuti-Castelvetri et al., 2018; Gilson and Blakemore, 1993; Hampton et al., 2012; Shen et al., 2008; Shields et al., 1999).”
BackgroundHerbig, U., Jobling, W. A., Chen, B. P. C., Chen, D. J., & Sedivy, J. M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00256-4 · Cited by 1,344 · cited 1×
“However, damaged senescent cells remain viable and have been shown to accumulate with normal ageing (Herbig et al., 2004; Lawless et al., 2010; Rodier and Campisi, 2011).”
BackgroundCytoplasmic chromatin triggers inflammation in senescence and cancer
Dou, Z., Ghosh, K., Vizioli, M. G., Zhu, J., Sen, P., Wangensteen, K. J., Simithy, J., Lan, Y., Lin, Y., Zhou, Z., et al. (2017) · Nature · doi:10.1038/nature24050 · Cited by 1,335
Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline
Bussian, T. J., Aziz, A., Meyer, C. F., Swenson, B. L., van Deursen, J. M., & Baker, D. J. (2018) · Nature · doi:10.1038/s41586-018-0543-y · Cited by 1,289
Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype
Wiley, C. D., Velarde, M. C., Lecot, P., Liu, S., Sarnoski, E. A., Freund, A., Shirakawa, K., Lim, H. W., Davis, S. S., Ramanathan, A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.11.011 · Cited by 1,275 · cited 3×
“Tumor necrosis factor-alpha (TNF-α), a component of SASP in mitochondrial dysfunction-associated senescence (Wiley et al., 2016), is a well-known driver of OPC proliferation (Arnett et al.”
Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination
Lappe-Siefke, C., Goebbels, S., Gravel, M., Nicksch, E., Lee, J., Braun, P. E., Griffiths, I. R., & Nave, K.-A. (2003) · Nature Genetics · doi:10.1038/ng1095 · Cited by 1,036
Feedback between p21 and reactive oxygen production is necessary for cell senescence
Passos, J. F., Nelson, G., Wang, C., Richter, T., Simillion, C., Proctor, C. J., Miwa, S., Olijslagers, S., Hallinan, J., Wipat, A., et al. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.5 · Cited by 1,019 · cited 2×
“Three mechanisms are thought to mediate the putative detrimental effects associated with the senescent phenotype: First, an inflammatory milieu is promoted by senescent cells that may act as continuous sources of pro-inflammatory mediators and reactive oxygen species (Passos et al., 2010).”
BackgroundTNFα promotes proliferation of oligodendrocyte progenitors and remyelination
Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., & Ting, J. P.-Y. (2001) · Nature Neuroscience · doi:10.1038/nn738 · Cited by 1,012 · cited 1×
“Tumor necrosis factor-alpha (TNF-α), a component of SASP in mitochondrial dysfunction-associated senescence (Wiley et al., 2016), is a well-known driver of OPC proliferation (Arnett et al., 2001).”
BackgroundcGAS is essential for cellular senescence
Yang, H., Wang, H., Ren, J., Chen, Q., & Chen, Z. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705499114 · Cited by 1,009
Premyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010994 · Cited by 991
Zhang, P., Kishimoto, Y., Grammatikakis, I., Gottimukkala, K., Cutler, R. G., Zhang, S., Abdelmohsen, K., Bohr, V. A., Misra Sen, J., Gorospe, M., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0372-9 · Cited by 977
Origin of oligodendrocytes in the subventricular zone of the adult brain
Menn, B., Garcia-Verdugo, J. M., Yaschine, C., Gonzalez-Perez, O., Rowitch, D., & Alvarez-Buylla, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1299-06.2006 · Cited by 972
Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30475-6 · Cited by 942
Axonal Swellings and Degeneration in Mice Lacking the Major Proteolipid of Myelin
Griffiths, I., Klugmann, M., Anderson, T., Yool, D., Thomson, C., Schwab, M. H., Schneider, A., Zimmermann, F., McCulloch, M., Nadon, N., et al. (1998) · Science · doi:10.1126/science.280.5369.1610 · Cited by 889
Noble, M., Murray, K., Stroobant, P., Waterfield, M. D., & Riddle, P. (1988) · Nature · doi:10.1038/333560a0 · Cited by 830
Myelin Impairs CNS Remyelination by Inhibiting Oligodendrocyte Precursor Cell Differentiation
Kotter, M. R., Li, W.-W., Zhao, C., & Franklin, R. J. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2615-05.2006 · Cited by 768
T-helper-1-cell cytokines drive cancer into senescence
Braumüller, H., Wieder, T., Brenner, E., Aßmann, S., Hahn, M., Alkhaled, M., Schilbach, K., Essmann, F., Kneilling, M., Griessinger, C., et al. (2013) · Nature · doi:10.1038/nature11824 · Cited by 720
Toussaint, O., Medrano, E. E., & von Zglinicki, T. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00180-7 · Cited by 713 · cited 1×
“, 2013), hyperoxia (Toussaint et al., 2000), impaired autophagy (Kang et al.”
Mechanisms of axon ensheathment and myelin growth
Sherman, D. L., & Brophy, P. J. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1743 · Cited by 668 · cited 1×
“Myelin secures saltatory conduction by affecting the distribution and spatial arrangement of a variety of voltage-dependent ion channel proteins along the node, paranodal and juxtaparanodal regions (Poliak and Peles, 2003; Sherman and Brophy, 2005).”
BackgroundMechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
Friese, M. A., Schattling, B., & Fugger, L. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.37 · Cited by 628
TGF-β Family Signaling in the Control of Cell Proliferation and Survival
Zhang, Y., Alexander, P. B., & Wang, X.-F. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022145 · Cited by 626
Sim, F. J., Zhao, C., Penderis, J., & Franklin, R. J. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02451.2002 · Cited by 625
Age-related myelin degradation burdens the clearance function of microglia during aging
Safaiyan, S., Kannaiyan, N., Snaidero, N., Brioschi, S., Biber, K., Yona, S., Edinger, A. L., Jung, S., Rossner, M. J., & Simons, M. (2016) · Nature Neuroscience · doi:10.1038/nn.4325 · Cited by 604
Jurk, D., Wang, C., Miwa, S., Maddick, M., Korolchuk, V., Tsolou, A., Gonos, E. S., Thrasivoulou, C., Jill Saffrey, M., Cameron, K., et al. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00870.x · Cited by 598
Tau protein aggregation is associated with cellular senescence in the brain
Musi, N., Valentine, J. M., Sickora, K. R., Baeuerle, E., Thompson, C. S., Shen, Q., & Orr, M. E. (2018) · Aging Cell · doi:10.1111/acel.12840 · Cited by 595 · cited 1×
“, 2020), or senolytic and senomorphic treatments on neurodegeneration in vivo (Bussian et al., 2018; Musi et al., 2018; Zhang et al., 2019) reveal the extent of senescent state contribution to neuropathology.”
Astrocyte Senescence as a Component of Alzheimer’s Disease
Bhat, R., Crowe, E. P., Bitto, A., Moh, M., Katsetos, C. D., Garcia, F. U., Johnson, F. B., Trojanowski, J. Q., Sell, C., & Torres, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045069 · Cited by 586 · cited 1×
“Cellular senescence has also been shown to affect neurons, microglia, astrocytes, pericytes and endothelial cells (Bhat et al., 2012; Kiss et al., 2020; Safaiyan et al., 2016; Yamazaki et al., 2016), cell types which may directly or indirectly influence the efficiency of myelin repair.”
Defective cholesterol clearance limits remyelination in the aged central nervous system
Cantuti-Castelvetri, L., Fitzner, D., Bosch-Queralt, M., Weil, M.-T., Su, M., Sen, P., Ruhwedel, T., Mitkovski, M., Trendelenburg, G., Lütjohann, D., et al. (2018) · Science · doi:10.1126/science.aan4183 · Cited by 586 · cited 3×
“In most experimental models of toxin-induced demyelination, as well as in Abbreviations: AD, Alzheimer’s disease; BBB, blood-brain barrier; BDNF, brain-derived neurotrophic factor; CCL19, chemokine (C-C motif) ligand 19; CDKN2a, cyclin dependent kinase inhibitor 2a; CHD7, chromodomain-helicase-DNA-binding protein 7; C…”
BackgroundSynthetic lethal metabolic targeting of cellular senescence in cancer therapy
Dörr, J. R., Yu, Y., Milanovic, M., Beuster, G., Zasada, C., Däbritz, J. H. M., Lisec, J., Lenze, D., Gerhardt, A., Schleicher, K., et al. (2013) · Nature · doi:10.1038/nature12437 · Cited by 541
Chinta, S. J., Woods, G., Demaria, M., Rane, A., Zou, Y., McQuade, A., Rajagopalan, S., Limbad, C., Madden, D. T., Campisi, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.092 · Cited by 530
NOTCH1 mediates a switch between two distinct secretomes during senescence
Hoare, M., Ito, Y., Kang, T.-W., Weekes, M. P., Matheson, N. J., Patten, D. A., Shetty, S., Parry, A. J., Menon, S., Salama, R., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3397 · Cited by 522
Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives
Baker, D. J., & Petersen, R. C. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95145 · Cited by 514 · cited 1×
“In recent years, accumulating evidence links cellular senescence to a variety of neurodegenerative conditions, such as in Alzheimer’s (AD) and Parkinson’s diseases (PD), both in patients and animal models (Baker and Petersen, 2018; Kritsilis et al., 2018; Martínez-Cué and Rueda, 2020), sometimes even implicating senes…”
Remyelination in multiple sclerosis
Prineas, J. W., & Connell, F. (1979) · Annals of Neurology · doi:10.1002/ana.410050105 · Cited by 454 · cited 1×
“inner and the outer diameter of the myelin membrane) (Prineas and Connell, 1979).”
Metformin restores CNS remyelination capacity by rejuvenating aged stem cells
Neumann, B., Baror, R., Zhao, C., Segel, M., Dietmann, S., Rawji, K. S., Foerster, S., McClain, C. R., Chalut, K., van Wijngaarden, P., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.08.015 · Cited by 449
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Self-citationRemyelination protects axons from demyelination-associated axon degeneration
Irvine, K. A., & Blakemore, W. F. (2008) · Brain · doi:10.1093/brain/awn080 · Cited by 420
Remyelination capacity of the MS brain decreases with disease chronicity
Goldschmidt, T., Antel, J., König, F. B., Brück, W., & Kuhlmann, T. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a8260a · Cited by 411 · cited 5×
“…exhibit less extensive remyelination in comparison to subcortical ones (Goldschmidt et al., 2009; Patrikios et al., 2006), or that in contrary to other brain regions cerebellar lesions remain largely demyelinated (Goldschmidt et al., 2009), also highlight the significance of lesion localization.”
BackgroundInfluentialTGF-β Signaling in Cellular Senescence and Aging-Related Pathology
Tominaga, K., & Suzuki, H. I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205002 · Cited by 393 · cited 1×
“TGF-β is a pleiotropic cytokine regulating a plethora of physiological and pathological cellular processes including myelin development and repair (Tominaga and Suzuki, 2019).”
BackgroundMeningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.
Choi, S. R., Howell, O. W., Carassiti, D., Magliozzi, R., Gveric, D., Muraro, P. A., Nicholas, R., Roncaroli, F., & Reynolds, R. (2012) · Brain · doi:10.1093/brain/aws189 · Cited by 386
Luchetti, S., Fransen, N. L., van Eden, C. G., Ramaglia, V., Mason, M., & Huitinga, I. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1818-y · Cited by 355 · cited 1×
“MS and those following a progressive course (Luchetti et al., 2018).”
Central nervous system regeneration is driven by microglia necroptosis and repopulation
Lloyd, A. F., Davies, C. L., Holloway, R. K., Labrak, Y., Ireland, G., Carradori, D., Dillenburg, A., Borger, E., Soong, D., Richardson, J. C., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0418-z · Cited by 340 · cited 1×
“repair (Lloyd et al., 2019), or microbiota producing butyrate, which acts as a histone deacetylase (HDAC) inhibitor (Chen et al.”
Minagawa, S., Araya, J., Numata, T., Nojiri, S., Hara, H., Yumino, Y., Kawaishi, M., Odaka, M., Morikawa, T., Nishimura, S. L., et al. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00097.2010 · Cited by 323
Extensive cortical remyelination in patients with chronic multiple sclerosis
Albert, M., Antel, J., Brück, W., & Stadelmann, C. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2006.00043.x · Cited by 314 · cited 1×
“frequently remyelinated than white matter lesions (Albert et al., 2007; Chang et al., 2012; Strijbis et al., 2017).”
Charles, P., Hernandez, M. P., Stankoff, B., Aigrot, M. S., Colin, C., Rougon, G., Zalc, B., & Lubetzki, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100076197 · Cited by 306
Tripathi, R. B., Rivers, L. E., Young, K. M., Jamen, F., & Richardson, W. D. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3411-10.2010 · Cited by 277 · cited 1×
“Genetic lineage tracing methodologies have shown that NG2+ adult OPCs residing in the adult CNS are primarily responsible for remyelination following demyelinating insults (Tripathi et al., 2010; Zawadzka et al., 2010).”
BackgroundXing, Y. L., Röth, P. T., Stratton, J. A. S., Chuang, B. H. A., Danne, J., Ellis, S. L., Ng, S. W., Kilpatrick, T. J., & Merson, T. D. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3491-13.2014 · Cited by 275 · cited 1×
“Also, subventricular zone (SVZ), one of the two neurogenic niches in the adult brain, can provide additional progenitor cells to the new myelinating cell population (Mecha et al., 2013; Menn et al., 2006; Xing et al., 2014).”
Vascular Cell Senescence Contributes to Blood–Brain Barrier Breakdown
Yamazaki, Y., Baker, D. J., Tachibana, M., Liu, C.-C., van Deursen, J. M., Brott, T. G., Bu, G., & Kanekiyo, T. (2016) · Stroke · doi:10.1161/strokeaha.115.010835 · Cited by 263
Robust, universal biomarker assay to detect senescent cells in biological specimens
Evangelou, K., Lougiakis, N., Rizou, S. V., Kotsinas, A., Kletsas, D., Muñoz‐Espín, D., Kastrinakis, N. G., Pouli, N., Marakos, P., Townsend, P., et al. (2017) · Aging Cell · doi:10.1111/acel.12545 · Cited by 259
Self-citationSenescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy
Oubaha, M., Miloudi, K., Dejda, A., Guber, V., Mawambo, G., Germain, M.-A., Bourdel, G., Popovic, N., Rezende, F. A., Kaufman, R. J., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf9440 · Cited by 259 · cited 4×
“, 2007), is secreted by senescent neurons in oxygen-induced retinopathy, as part of SASP (Oubaha et al., 2016; Sapieha and Mallette, 2018).”
BackgroundInfluentialThe adult oligodendrocyte can participate in remyelination
Duncan, I. D., Radcliff, A. B., Heidari, M., Kidd, G., August, B. K., & Wierenga, L. A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808064115 · Cited by 259
Oncogene-induced senescence: the bright and dark side of the response
Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.07.013 · Cited by 257
Self-citationAutophagy Impairment Induces Premature Senescence in Primary Human Fibroblasts
Kang, H. T., Lee, K. B., Kim, S. Y., Choi, H. R., & Park, S. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023367 · Cited by 254 · cited 1×
“impaired autophagy (Kang et al., 2011) and mitochondrial dysfunction (Wiley et al.”
Quantitative assessment of markers for cell senescence
Lawless, C., Wang, C., Jurk, D., Merz, A., Zglinicki, T. V., & Passos, J. F. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.01.018 · Cited by 240 · cited 1×
“However, damaged senescent cells remain viable and have been shown to accumulate with normal ageing (Herbig et al., 2004; Lawless et al., 2010; Rodier and Campisi, 2011).”
The role of inflammation in age-related disease
Howcroft, T. K., Campisi, J., Louis, G. B., Smith, M. T., Wise, B., Wyss-Coray, T., Augustine, A. D., McElhaney, J. E., Kohanski, R., & Sierra, F. (2013) · Aging · doi:10.18632/aging.100531 · Cited by 239
Wiley, C. D., Flynn, J. M., Morrissey, C., Lebofsky, R., Shuga, J., Dong, X., Unger, M. A., Vijg, J., Melov, S., & Campisi, J. (2017) · Aging Cell · doi:10.1111/acel.12632 · Cited by 234 · cited 1×
“, 2011) and mitochondrial dysfunction (Wiley et al., 2017).”
Butyrate suppresses demyelination and enhances remyelination
Chen, T., Noto, D., Hoshino, Y., Mizuno, M., & Miyake, S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1552-y · Cited by 229
Interleukin-1 Regulates Proliferation and Differentiation of Oligodendrocyte Progenitor Cells
Vela, J. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1127 · Cited by 223 · cited 1×
“(Vela et al., 2002), is secreted by senescent astrocytes after highly active antiretroviral”
Cortical remyelination: A new target for repair therapies in multiple sclerosis
Chang, A., Staugaitis, S. M., Dutta, R., Batt, C. E., Easley, K. E., Chomyk, A. M., Yong, V. W., Fox, R. J., Kidd, G. J., & Trapp, B. D. (2012) · Annals of Neurology · doi:10.1002/ana.23693 · Cited by 216 · cited 1×
“Polysialic acid (PSA), an inhibitor of developmental myelination (Charles et al., 2000) and remyelination in the cuprizone model (Koutsoudaki et al., 2010), is also found to be re-expressed in denuded axons in chronic MS lesions (Charles, 2002).”
BackgroundNotch1 signaling plays a role in regulating precursor differentiation during CNS remyelination
Zhang, Y., Argaw, A. T., Gurfein, B. T., Zameer, A., Snyder, B. J., Ge, C., Lu, Q. R., Rowitch, D. H., Raine, C. S., Brosnan, C. F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902834106 · Cited by 210 · cited 1×
“TGF-β1 is implicated in oligodendrocyte maturation through induction of expression of the Notch ligand Jagged-1 in astrocytes, an action mediated by TGFRβ-RI and Smad3 (Zhang et al., 2010).”
BackgroundKiss, T., Nyúl-Tóth, Á., Balasubramanian, P., Tarantini, S., Ahire, C., DelFavero, J., Yabluchanskiy, A., Csipo, T., Farkas, E., Wiley, G., et al. (2020) · GeroScience · doi:10.1007/s11357-020-00177-1 · Cited by 203
Associative Learning in Invertebrates
Hawkins, R. D., & Byrne, J. H. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021709 · Cited by 199
Cellular Senescence in Postmitotic Cells: Beyond Growth Arrest
Sapieha, P., & Mallette, F. A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.03.003 · Cited by 193 · cited 15×
“FGF2 (Fibroblast growth factor 2), a factor affecting oligodendroglial lineage cells in a pleiotropic manner both in development and remyelination, is secreted by senescent cells as part of their SASP (Coppé et al., 2010).”
InfluentialTransient Activation of p53 in G2 Phase Is Sufficient to Induce Senescence
Krenning, L., Feringa, F. M., Shaltiel, I. A., van den Berg, J., & Medema, R. H. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.05.007 · Cited by 193
Astrocyte senescence promotes glutamate toxicity in cortical neurons
Limbad, C., Oron, T. R., Alimirah, F., Davalos, A. R., Tracy, T. E., Gan, L., Desprez, P.-Y., & Campisi, J. (2020) · PLOS ONE · doi:10.1371/journal.pone.0227887 · Cited by 183
Armstrong, R. C., Le, T. Q., Frost, E. E., Borke, R. C., & Vana, A. C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-19-08574.2002 · Cited by 178 · cited 1×
“efficiently than wild-type animals (Armstrong et al., 2002; Tobin et al., 2011).”
The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS
Reynolds, R., Dawson, M., Papadopoulos, D., Polito, A., di Bello, I. C., Pham-Dinh, D., & Levine, J. (2002) · Journal of Neurocytology · doi:10.1023/a:1025747832215 · Cited by 175 · cited 2×
“In general, after appropriate cues from their milieu, OPCs undergo asymmetric division and migrate towards the lesion site, guided by chemoattractant factors such as Semaphorin 3F (Reynolds et al., 2002; Galloway et al., 2019).”
BackgroundSelf-citationCellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling
Rajagopalan, S., & Long, E. O. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208248109 · Cited by 168 · cited 1×
“…conversion and recent evidence also support a role of cellular senescence in several development processes (Barbouti et al., 2019; Demaria et al., 2014; Muñoz-Espín and Serrano, 2014; P.N. Koutsoudaki et al. Mechanisms of Ageing and Development 192 (2020) 111366 Rajagopalan and Long, 2012).”
BackgroundLIEBETANZ, D., & MERKLER, D. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.05.032 · Cited by 166 · cited 2×
“have the capacity to restore saltatory conduction (Franklin and Goldman, 2015; Liebetanz and Merkler, 2006; Smith et al., 1979).”
BackgroundKandhaya-Pillai, R., Miro-Mur, F., Alijotas-Reig, J., Tchkonia, T., Kirkland, J. L., & Schwartz, S. (2017) · Aging · doi:10.18632/aging.101328 · Cited by 165
Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions
Ambrosini, E., Remoli, M. E., Giacomini, E., Rosicarelli, B., Serafini, B., Lande, R., Aloisi, F., & Coccia, E. M. (2005) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000173893.01929.fc · Cited by 161
Senescence and senotherapeutics: a new field in cancer therapy
Myrianthopoulos, V., Evangelou, K., Vasileiou, P. V. S., Cooks, T., Vassilakopoulos, T. P., Pangalis, G. A., Kouloukoussa, M., Kittas, C., Georgakilas, A. G., & Gorgoulis, V. G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.08.006 · Cited by 160 · cited 2×
“However, the senescent state can also be triggered by numerous stressors including aberrant oncogene activation (Gorgoulis et al., 2019; Gorgoulis and Halazonetis, 2010; Myrianthopoulos et al., 2019), oxidative stress (Hernandez-Segura et al.”
Self-citationNo evidence for chronic demyelination in spared axons after spinal cord injury in a mouse
Lasiene, J., Shupe, L., Perlmutter, S., & Horner, P. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4756-07.2008 · Cited by 133 · cited 1×
“In most experimental models of toxin-induced demyelination, as well as in traumatic injuries, remyelination is usually extensive and complete (Lasiene et al., 2008).”
Gene expression profiling of replicative and induced senescence
Purcell, M., Kruger, A., & Tainsky, M. A. (2014) · Cell Cycle · doi:10.4161/15384101.2014.973327 · Cited by 132
Velimezi, G., Liontos, M., Vougas, K., Roumeliotis, T., Bartkova, J., Sideridou, M., Dereli-Oz, A., Kocylowski, M., Pateras, I. S., Evangelou, K., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2795 · Cited by 131
Self-citationTurenne, G. A., Paul, P., Laflair, L., & Price, B. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204665 · Cited by 120 · cited 1×
“Most of these triggers lead to DNA damage and typically activate the complex signal transduction system of DNA damage response (DDR), which may elicit CS (Nakamura et al., 2008; Rodier and Campisi, 2011; Turenne et al., 2001).”
Radiation-induced astrocyte senescence is rescued by Δ133p53
Turnquist, C., Beck, J. A., Horikawa, I., Obiorah, I. E., Von Muhlinen, N., Vojtesek, B., Lane, D. P., Grunseich, C., Chahine, J. J., Ames, H. M., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz001 · Cited by 118
Papadopoulos, D., Pham-Dinh, D., & Reynolds, R. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.10.033 · Cited by 115
Self-citationKujuro, Y., Suzuki, N., & Kondo, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911446107 · Cited by 94
Cortical remyelination is heterogeneous in multiple sclerosis
Strijbis, E. M. M., Kooi, E.-J., van der Valk, P., & Geurts, J. J. G. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx023 · Cited by 82 · cited 1×
“10 are more frequently remyelinated than white matter lesions (Albert et al., 2007; Chang et al., 2012; Strijbis et al., 2017).”
Śmieszek, A., Stręk, Z., Kornicka, K., Grzesiak, J., Weiss, C., & Marycz, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040872 · Cited by 77
Willis, C. M., Nicaise, A. M., Bongarzone, E. R., Givogri, M., Reiter, C. R., Heintz, O., Jellison, E. R., Sutter, P. A., TeHennepe, G., Ananda, G., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-57663-x · Cited by 76 · cited 3×
“…cultures of primary murine astrocytes Astrocytes Downregulation of CS markers and maintenance of ability to promote primary rat OPC differentiation Willis et al., 2020 ginsenosides F1 and Rg3 p38MAPK inhibitors human and rat primary cultures Astrocytes Prevention of H2O2-induced CS and decrease…”
BackgroundInfluentialiPS-derived neural progenitor cells from PPMS patients reveal defect in myelin injury response
Nicaise, A. M., Banda, E., Guzzo, R. M., Russomanno, K., Castro-Borrero, W., Willis, C. M., Johnson, K. M., Lo, A. C., & Crocker, S. J. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2016.11.012 · Cited by 64 · cited 1×
“controls, which promoted OPC maturation efficiently (Nicaise et al., 2017).”
Astrocyte senescence and metabolic changes in response to HIV antiretroviral therapy drugs
Cohen, J., D’Agostino, L., Wilson, J., Tuzer, F., & Torres, C. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00281 · Cited by 58
Baror, R., Neumann, B., Segel, M., Chalut, K. J., Fancy, S. P. J., Schafer, D. P., & Franklin, R. J. M. (2019) · Glia · doi:10.1002/glia.23612 · Cited by 54 · cited 1×
“oligodendrocyte differentiation from OPCs (Baror et al., 2019).”
Barbouti, A., Evangelou, K., Pateras, I. S., Papoudou-Bai, A., Patereli, A., Stefanaki, K., Rontogianni, D., Muñoz-Espín, D., Kanavaros, P., & Gorgoulis, V. G. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.02.005 · Cited by 44
Self-citationKoutsoudaki, P. N., Hildebrandt, H., Gudi, V., Skripuletz, T., Škuljec, J., & Stangel, M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.070 · Cited by 37
Self-citationSharma, V., Gilhotra, R., Dhingra, D., & Gilhotra, N. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11026fp · Cited by 31 · cited 1×
“The senescent state is typically associated with stable cell cycle arrest and the expression of a senescence-associated secretory phenotype (SASP) (Dou et al., 2017; Hoare et al., 2016; Sharma et al., 2011; Yang et al., 2017).”
Background
Research works printed but not linked: 123
- Alizadeh, 2015, Myelin damage and repair in pathologic CNS: challenges and prospects, Front. Mol. Neurosci., 8, 1, 10.3389/fnmol.2015.00035 · DOI · Paper page
- Baranzini, 2000, Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression, J. Immunol., 165, 6576, 10.4049/jimmunol.165.11.6576 · DOI · Paper page
- Baron, 2000, Perturbation of myelination by activation of distinct signaling pathways: an in vitro study in a myelinating culture derived from fetal rat brain, J. Neurosci. Res., 59, 74, 10.1002/(SICI)1097-4547(20000101)59:1<74::AID-JNR9>3.0.CO;2-P · DOI
- Bevan, 2018, Meningeal inflammation and cortical demyelination in acute multiple sclerosis, Ann. Neurol., 84, 829, 10.1002/ana.25365 · DOI · Paper page
- Bin, 2013, Full-length and fragmented netrin-1 in multiple sclerosis plaques are inhibitors of oligodendrocyte precursor cell migration, Am. J. Pathol., 183, 673, 10.1016/j.ajpath.2013.06.004 · DOI
- Black, 2006, Remyelination of dorsal column axons by endogenous Schwann cells restores the normal pattern of Na v1.6 and K v1.2 at nodes of Ranvier, Brain, 129, 1319, 10.1093/brain/awl057 · DOI
- Bodini, 2016, Dynamic imaging of individual remyelination profiles in multiple sclerosis, Ann. Neurol., 79, 726, 10.1002/ana.24620 · DOI · Paper page
- Boyd, 2013, Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models, Acta Neuropathol., 125, 841, 10.1007/s00401-013-1112-y · DOI · Paper page
- Bramow, 2010, Demyelination versus remyelination in progressive multiple sclerosis, Brain, 133, 2983, 10.1093/brain/awq250 · DOI · Paper page
- Brown, 2014, Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis, Neuroimage Clin., 6, 20, 10.1016/j.nicl.2014.06.009 · DOI · Paper page
- Burbidge, 2002, Molecular cloning, distribution and functional analysis of the NAV1.6. Voltage-gated sodium channel from human brain, Mol. Brain Res., 103, 80, 10.1016/S0169-328X(02)00188-2 · DOI
- Butt, 2005, Opposing actions of fibroblast growth factor-2 on early and late oligodendrocyte lineage cells in vivo, J. Neuroimmunol., 166, 75, 10.1016/j.jneuroim.2005.05.015 · DOI
- Cadavid, 2017, Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial, Lancet Neurol., 16, 189, 10.1016/S1474-4422(16)30377-5 · DOI · Paper page
- Cadavid, 2019, Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial, Lancet Neurol., 18, 845, 10.1016/S1474-4422(19)30137-1 · DOI · Paper page
- Chamberlain, 2016, Oligodendrocyte regeneration: its significance in myelin replacement and neuroprotection in multiple sclerosis, Neuropharmacology, 10.1016/j.neuropharm.2015.10.010 · DOI · Paper page
- Chang, 2000, NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions, J. Neurosci., 10.1523/JNEUROSCI.20-17-06404.2000 · DOI · Paper page
- Charles, 2002, Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis?, Brain, 125, 1972, 10.1093/brain/awf216 · DOI · Paper page
- Coman, 2006, Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis, Brain, 129, 3186, 10.1093/brain/awl144 · DOI · Paper page
- Coppé, 2010, The senescence-associated secretory phenotype: the dark side of tumor suppression, Annu. Rev. Pathol. Mech. Dis., 5, 99, 10.1146/annurev-pathol-121808-102144 · DOI · Paper page
- Craner, 2004, Co- localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE, Brain, 127, 294, 10.1093/brain/awh032 · DOI · Paper page
- Crawford, 2016, Pre-existing mature oligodendrocytes do not contribute to remyelination following toxin-induced spinal cord demyelination, Am. J. Pathol., 186, 511, 10.1016/j.ajpath.2015.11.005 · DOI · Paper page
- Cunniffe, 2019, Promoting remyelination in multiple sclerosis, J. Neurol.
- Dawson, 2000, NG2-expressing cells in the central nervous system: are they oligodendroglial progenitors?, J. Neurosci. Res., 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.0.CO;2-N · DOI · Paper page
- De Angelis, 2018, Disease-modifying therapies for multiple sclerosis, BMJ, 4674, 1
- de Barcelos, 2019, Mitochondrial dysfunction and multiple sclerosis, Biology (Basel), 8
- de Jong, 2018, Galectin-4, a negative regulator of oligodendrocyte differentiation, is persistently present in axons and microglia/ macrophages in multiple sclerosis lesions, J. Neuropathol. Exp. Neurol., 77, 1024, 10.1093/jnen/nly081 · DOI
- Debacq-Chainiaux, 2005, Repeated exposure of human skin fibroblasts to UVB at subcytotoxic level triggers premature senescence through the TGF-β1 signaling pathway, J. Cell. Sci., 118, 743, 10.1242/jcs.01651 · DOI · Paper page
- Dusart, 1992, Demyelination, and remyelination by Schwann cells and oligodendrocytes after kainate-induced neuronal depletion in the central nervous system, Neuroscience, 51, 137, 10.1016/0306-4522(92)90478-K · DOI · Paper page
- Dutta, 2006, Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients, Ann. Neurol., 59, 478, 10.1002/ana.20736 · DOI · Paper page
- El Behi, 2017, Adaptive human immunity drives remyelination in a mouse model of demyelination, Brain, 140, 967, 10.1093/brain/awx008 · DOI · Paper page
- Evangelou, 2013, The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis, Cell Death Differ., 20, 1485, 10.1038/cdd.2013.76 · DOI · Paper page
- Fancy, 2009, Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS, Genes Dev., 23, 1571, 10.1101/gad.1806309 · DOI · Paper page
- Felts, 1992, Conduction properties of central nerve fibers remyelinated by Schwann cells, Brain Res., 574, 178, 10.1016/0006-8993(92)90815-Q · DOI
- Felts, 2005, Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide, Brain, 128, 1649, 10.1093/brain/awh516 · DOI · Paper page
- Foerster, 2019, Diversity in the oligodendrocyte lineage: plasticity or heterogeneity?, Glia, 10.1002/glia.23607 · DOI
- Franklin, 2015, Glia disease and repair—remyelination, Cold Spring Harb. Perspect. Biol., 7, 1, 10.1101/cshperspect.a020594 · DOI · Paper page
- Galloway, 2019, Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination, Glia
- Gilson, 1993, Failure of remyelination in areas of demyelination produced in the spinal cord of old rats, Neuropathol. Appl. Neurobiol., 19, 173, 10.1111/j.1365-2990.1993.tb00424.x · DOI · Paper page
- Goddard, 2001, Fibroblast growth factor-2 inhibits myelin production by oligodendrocytes in vivo, Mol. Cell. Neurosci., 18, 557, 10.1006/mcne.2001.1025 · DOI · Paper page
- Haider, 2014, Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron, J. Neurol. Neurosurg. Psychiatry, 85, 1386, 10.1136/jnnp-2014-307712 · DOI · Paper page
- Hamada, 2015, Myelin loss and axonal ion channel adaptations associated with gray matter neuronal hyperexcitability, J. Neurosci., 35, 7272, 10.1523/JNEUROSCI.4747-14.2015 · DOI · Paper page
- Hamanaka, 2018, White-matter repair: interaction between oligodendrocytes and the neurovascular unit, Brain Circ., 4, 118, 10.4103/bc.bc_15_18 · DOI · Paper page
- Hampton, 2012, Focal immune-mediated white matter demyelination reveals an age-associated increase in axonal vulnerability and decreased remyelination efficiency, Am. J. Pathol., 180, 1897, 10.1016/j.ajpath.2012.01.018 · DOI
- Hayflick, 1961, The serial cultivation of human diploid cell strains, Exp. Cell Res., 25, 585, 10.1016/0014-4827(61)90192-6 · DOI · Paper page
- He, 2016, Chd7 cooperates with Sox10 and regulates the onset of CNS myelination and remyelination, Nat. Neurosci., 19, 678, 10.1038/nn.4258 · DOI · Paper page
- Hoffmann, 2014, Stem cell factor Sox2 and its close relative Sox3 have differentiation functions in oligodendrocytes, Dev., 141, 39, 10.1242/dev.098418 · DOI · Paper page
- Horiuchi, 2012, Amyloid β1-42 oligomer inhibits myelin sheet formation in vitro, Neurobiol. Aging, 33, 499, 10.1016/j.neurobiolaging.2010.05.007 · DOI · Paper page
- Hou, 2017, Ginsenoside Rg3 prevents oxidative stress-induced astrocytic senescence and ameliorates senescence paracrine effects on glioblastoma, Molecules, 22, 10.3390/molecules22091516 · DOI · Paper page
- Hou, 2018, Ginsenoside F1 suppresses astrocytic senescence-associated secretory phenotype, Chem. Biol. Interact., 283, 75, 10.1016/j.cbi.2018.02.002 · DOI
- Itoyama, 1983, Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions, Ann. Neurol., 14, 339, 10.1002/ana.410140313 · DOI · Paper page
- Jarjour, 2003, Netrin-1 is a chemorepellent for oligodendrocyte precursor cells in the embryonic spinal cord, J. Neurosci., 23, 3735, 10.1523/JNEUROSCI.23-09-03735.2003 · DOI · Paper page
- Jeffries, 2016, ERK1/2 activation in preexisting oligodendrocytes of adult mice drives new myelin synthesis and enhanced CNS function, J. Neurosci., 36, 9186, 10.1523/JNEUROSCI.1444-16.2016 · DOI · Paper page
- John, 2002, Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation, Nat. Med., 8, 1115, 10.1038/nm781 · DOI · Paper page
- Kernt, 2013, Idebenone prevents human optic nerve head astrocytes from oxidative stress, apoptosis, and senescence by stabilizing BAX/Bcl-2 ratio, J Glaucoma, 22, 404, 10.1097/IJG.0b013e31824caf90 · DOI
- Kornek, 2000, Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions, Am. J. Pathol., 157, 267, 10.1016/S0002-9440(10)64537-3 · DOI · Paper page
- Kremer, 2019, Current advancements in promoting remyelination in multiple sclerosis, Mult. Scler. J., 10.1177/1352458518800827 · DOI
- Kuhlmann, 2008, Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis, Brain, 131, 1749, 10.1093/brain/awn096 · DOI · Paper page
- Lalive, 2005, TGF-β-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway, Eur. J. Immunol., 35, 727, 10.1002/eji.200425430 · DOI · Paper page
- Lassmann, 2016, Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions, Biochim. Biophys. Acta Mol. Basis Dis, 1862, 506, 10.1016/j.bbadis.2015.09.018 · DOI · Paper page
- Lentferink, 2018, Grey matter OPCs are less mature and less sensitive to IFNγ than white matter OPCs: consequences for remyelination, Sci. Rep., 8, 10.1038/s41598-018-19934-6 · DOI
- Leray, 2010, Evidence for a two-stage disability progression in multiple sclerosis, Brain, 133, 1900, 10.1093/brain/awq076 · DOI · Paper page
- Lin, 2012, Attenuation of TGF-β signaling suppresses premature senescence in a p21-dependent manner and promotes oncogenic Ras-mediated metastatic transformation in human mammary epithelial cells, Mol. Biol. Cell, 23, 1569, 10.1091/mbc.e11-10-0849 · DOI · Paper page
- Lloyd, 2016, Cellular and molecular mechanisms underpinning macrophage activation during remyelination, Front. Cell Dev. Biol., 10.3389/fcell.2016.00060 · DOI · Paper page
- Lovas, 2000, Axonal changes in chronic demyelinated cervical spinal cord plaques, Brain, 123, 308, 10.1093/brain/123.2.308 · DOI · Paper page
- Ludwin, 1984, Long-term remyelination fails to reconstitute normal thickness of central myelin sheaths, J. Neurol. Sci., 64, 193, 10.1016/0022-510X(84)90037-6 · DOI
- Marqués-Torrejón, 2013, Cyclin-dependent kinase inhibitor p21 controls adult neural stem cell expansion by regulating Sox2 gene expression, Cell Stem Cell, 12, 88, 10.1016/j.stem.2012.12.001 · DOI · Paper page
- Martínez-Cué, 2020, Cellular senescence in neurodegenerative diseases, Front. Cell. Neurosci., 14, 10.3389/fncel.2020.00016 · DOI · Paper page
- McKay, 2015, Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic review, Biomed Res. Int., 10.1155/2015/817238 · DOI
- McKinnon, 1990, FGF modulates the PDGF-driven pathway of oligodendrocyte development, Neuron, 5, 603, 10.1016/0896-6273(90)90215-2 · DOI · Paper page
- Mecha, 2013, Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler’s virus model of multiple sclerosis: implications for remyelination at lesions sites, Exp. Neurol., 250, 348, 10.1016/j.expneurol.2013.10.011 · DOI
- Mei, 2016, Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery, Elife, 5, 10.7554/eLife.18246 · DOI · Paper page
- Mi, 2005, LINGO-1 negatively regulates myelination by oligodendrocytes, Nat. Neurosci., 8, 745, 10.1038/nn1460 · DOI · Paper page
- Milner, 1997, Contrasting effects of mitogenic growth factors on oligodendrocyte precursor cell migration, Glia, 19, 85, 10.1002/(SICI)1098-1136(199701)19:1<85::AID-GLIA9>3.0.CO;2-9 · DOI · Paper page
- Miron, 2011, Cells of the oligodendroglial lineage, myelination, and remyelination, Biochim. Biophys. Acta Mol. Basis Dis., 10.1016/j.bbadis.2010.09.010 · DOI · Paper page
- Mitew, 2018, Pharmacogenetic stimulation of neuronal activity increases myelination in an axon-specific manner, Nat. Commun., 9, 10.1038/s41467-017-02719-2 · DOI · Paper page
- Mitrovič, 2018, Low- frequency and rare-coding variation contributes to multiple sclerosis risk, Cell, 175, 1679, 10.1016/j.cell.2018.09.049 · DOI · Paper page
- Montalban, 2018, Cladribine tablets added to IFN-β in active relapsing MS, Neurol. Neuroimmunol. NeuroInflammation, 5, 10.1212/NXI.0000000000000477 · DOI
- Morgan-Hughes, 1968, Experimental diphtheritic neuropathy. A pathological and electrophysiological study, J. Neurol. Sci., 7, 157, 10.1016/0022-510X(68)90011-7 · DOI
- Muñoz- Espín, 2014, Cellular senescence: from physiology to pathology, Nat. Rev. Mol. Cell Biol., 10.1038/nrm3823 · DOI · Paper page
- Mutsaers, 1998, Focal accumulation of intra-axonal mitochondria in demyelination of the cat optic nerve, Acta Neuropathol., 96, 139, 10.1007/s004010050873 · DOI
- Nakamura, 2008, Both telomeric and non- telomeric DNA damage are determinants of mammalian cellular senescence, Epigenetics Chromatin, 1, 10.1186/1756-8935-1-6 · DOI · Paper page
- Nicaise, 2019, Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis, Proc. Natl. Acad. Sci. U. S. A., 116, 9030, 10.1073/pnas.1818348116 · DOI · Paper page
- Noble, 2003, The cortical ancestry of oligodendrocytes: common principles and novel features, Dev. Neurosci., 10.1159/000072270 · DOI
- Oost, 2018, Targeting senescence to delay progression of multiple sclerosis, J. Mol. Med., 10.1007/s00109-018-1686-x · DOI
- Ortiz, 2019, Neuronal activity in vivo enhances functional myelin repair, JCI Insight, 4, 10.1172/jci.insight.123434 · DOI · Paper page
- Papageorgis, 2017, Complex interplay between aging and cancer: role of TGF-β signaling, Crit. Rev. Oncog., 10.1615/CritRevOncog.2017025134 · DOI
- Pardo, 2017, The sequence of disease- modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations, J. Neurol.
- Patani, 2007, Remyelination can be extensive in multiple sclerosis despite a long disease course, Neuropathol Appl Neurobiol, 33, 277, 10.1111/j.1365-2990.2007.00805.x · DOI · Paper page
- Patrikios, 2006, Remyelination is extensive in a subset of multiple sclerosis patients, Brain, 129, 3165, 10.1093/brain/awl217 · DOI · Paper page
- Petersen, 2017, Fibrinogen activates BMP signaling in oligodendrocyte progenitor cells and inhibits remyelination after vascular damage, Neuron, 96, 1003, 10.1016/j.neuron.2017.10.008 · DOI · Paper page
- Poliak, 2003, The local differentiation of myelinated axons at nodes of ranvier, Nat. Rev. Neurosci., 10.1038/nrn1253 · DOI · Paper page
- Prozorovski, 2019, Regulation of sirtuin expression in autoimmune neuroinflammation: induction of SIRT1 in oligodendrocyte progenitor cells, Neurosci. Lett., 704, 116, 10.1016/j.neulet.2019.04.007 · DOI
- Raine, 2017, Multiple sclerosis: the resolving lesion revealed, J. Neuroimmunol., 304, 2, 10.1016/j.jneuroim.2016.05.021 · DOI
- Ren, 2009, Inflammatory signaling and cellular senescence, Cell. Signal., 10.1016/j.cellsig.2008.10.011 · DOI · Paper page
- Rivera, 2019, Aging restricts the ability of mesenchymal stem cells to promote the generation of oligodendrocytes during remyelination, Glia, 67, 1510, 10.1002/glia.23624 · DOI
- Sabin, 2011, Cellular Senescence - its role in cancer and the response to ionizing radiation, Genome Integr., 10.1186/2041-9414-2-7 · DOI · Paper page
- Saida, 1980, Antiserum‐mediated demyelination: relationship between remyelination and functional recovery, Ann. Neurol., 8, 12, 10.1002/ana.410080103 · DOI
- Scott-Hewitt, 2017, Heterozygote galactocerebrosidase (GALC) mutants have reduced remyelination and impaired myelin debris clearance following demyelinating injury, Hum. Mol. Genet., 26, 2825, 10.1093/hmg/ddx153 · DOI
- Sedal, 1983, A combined morphological and electrophysiological study of conduction block in peripheral nerve, J. Neurol. Sci., 60, 293, 10.1016/0022-510X(83)90070-9 · doi:10.1016/0022-510x(83)90070-9
- Shen, 2008, Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency, Nat. Neurosci., 11, 1024, 10.1038/nn.2172 · DOI · Paper page
- Shields, 1999, Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination, Glia, 28, 77, 10.1002/(SICI)1098-1136(199910)28:1<77::AID-GLIA9>3.0.CO;2-F · DOI · Paper page
- Shrager, 1988, Ionic channels and signal conduction in single remyelinating frog nerve fibres, J. Physiol., 404, 695, 10.1113/jphysiol.1988.sp017314 · doi:10.1113/jphysiol.1988.sp017314
- Smith, 1980, Nerve conduction during peripheral demyelination and remyelination, Top. Catal., 48, 201
- Smith, 1979, Central remyelination restores secure conduction [12], Nature
- Smith, 1981, The restoration of conduction by central remyelination, Brain, 104, 647, 10.1093/brain/104.2.383 · DOI · Paper page
- Stancic, 2012, Galectin-4, a novel neuronal regulator of myelination, Glia, 60, 919, 10.1002/glia.22324 · DOI · Paper page
- Tepavčević, 2014, Early netrin-1 expression impairs central nervous system remyelination, Ann. Neurol., 76, 252, 10.1002/ana.24201 · DOI · Paper page
- Thümmler, 2019, Polarizing receptor activation dissociates fibroblast growth factor 2 mediated inhibition of myelination from its neuroprotective potential, Acta Neuropathol. Commun., 7, 10.1186/s40478-019-0864-6 · DOI
- Tian, 2018, CXCL12 induces migration of oligodendrocyte precursor cells through the CXCR4‑activated MEK/ERK and PI3K/AKT pathways, Mol. Med. Rep., 18, 4374
- Tobin, 2011, Reduced axonopathy and enhanced remyelination after chronic demyelination in fibroblast growth factor 2 (Fgf2)-null mice: differential detection with diffusion tensor imaging, J. Neuropathol. Exp. Neurol., 70, 157, 10.1097/NEN.0b013e31820937e4 · DOI · Paper page
- Verden, 2016, Neuroprotection by central nervous system remyelination: molecular, cellular, and functional considerations, J. Neurosci. Res., 10.1002/jnr.23923 · DOI
- Wang, 1998, Notch receptor activation inhibits oligodendrocyte differentiation, Neuron, 21, 10.1016/S0896-6273(00)80515-2 · DOI · Paper page
- Williams, 2007, Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis?, Brain, 130, 2554, 10.1093/brain/awm202 · DOI · Paper page
- Xia, 2020, Astragaloside IV inhibits astrocyte senescence: implication in Parkinson’s disease, J. Neuroinflammation, 17, 105, 10.1186/s12974-020-01791-8 · DOI · Paper page
- Yabluchanskiy, 2020, Pharmacological or genetic depletion of senescent astrocytes prevents whole brain irradiation–induced impairment of neurovascular coupling responses protecting cognitive function in mice, GeroScience, 10.1007/s11357-020-00154-8 · DOI
- Yamada, 1998, White matter astrocytes produce hepatocyte growth factor activator inhibitor in human brain tissues, Exp. Neurol., 153, 60, 10.1006/exnr.1998.6874 · DOI
- Yin, 2014, Knockdown of Lingo1b protein promotes myelination and oligodendrocyte differentiation in zebrafish, Exp. Neurol., 251, 72, 10.1016/j.expneurol.2013.11.012 · DOI
- Zambonin, 2011, Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis, Brain, 134, 1901, 10.1093/brain/awr110 · DOI · Paper page
- Zawadzka, 2010, CNS-resident glial Progenitor/Stem cells produce schwann cells as well as oligodendrocytes during repair of CNS demyelination, Cell Stem Cell, 6, 578, 10.1016/j.stem.2010.04.002 · DOI · Paper page
- Zhang, 2010, TGFβ1 induces Jagged1 expression in astrocytes via ALK5 and Smad3 and regulates the balance between oligodendrocyte progenitor proliferation and differentiation, Glia, 58, 964, 10.1002/glia.20978 · DOI · Paper page
- Zhang, 2018, Sox2 is essential for oligodendroglial proliferation and differentiation during postnatal brain myelination and CNS remyelination, J. Neurosci., 38, 1802, 10.1523/JNEUROSCI.1291-17.2018 · DOI · Paper page
- Zhou, 2019, Age-related changes in the global DNA methylation profile of oligodendrocyte progenitor cells derived from rat spinal cords, Curr. Med. Sci., 39, 67, 10.1007/s11596-019-2001-y · DOI
- Zhu, 2014, Ginsenoside Rg1 prevents cognitive impairment and hippocampus senescence in a rat model of D-galactose-induced aging, PLoS One, 9
Cited by
Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration
Packer, D., Fresenko, E. E., & Harrington, E. P. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1207007 · Cited by 21
White Matter in Crisis: Oligodendrocytes and the Pathophysiology of Multiple Sclerosis
García-Domínguez, M. (2025) · Cells · doi:10.3390/cells14181408 · Cited by 13
Cellular Senescence in Glial Cells: Implications for Multiple Sclerosis
Maupin, E. A., & Adams, K. L. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16301 · Cited by 12
Microglial states associate with lesion dynamics in multiple sclerosis
van den Bosch, A. M. R., Khoo, J. H., Lu, Z., Liang, H., Wever, D., Pu, L., Eggen, B. J. L., Uhlén, M., Smolders, J., Hamann, J., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117538 · Cited by 13
Metadata
- Authors
- Koutsoudaki, P. N., Papadopoulos, D., Passias, P.-G., Koutsoudaki, P., & Gorgoulis, V. G.
- Venue
- Mechanisms of Ageing and Development
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 192
- Pages
- 111366
- ISSN
- 0047-6374 (ISSN-L)
- OpenAlex
- W3091536782
- Cited by
- 33
- References
- 96
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- Hellenic Foundation for Research and Innovation
- H2020 Marie Skłodowska-Curie Actions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.